Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Acer Therapeutics Inc.
Newton, Massachusetts
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated March 18, 2020, relating to the consolidated financial statements of Acer Therapeutics Inc. appearing in the Company’s Annual Report on Form10-K for the year ended December 31, 2019. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/ BDO USA, LLP |
Boston, Massachusetts March 18, 2020 |